好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Anti-GAGA4 IgM Antibodies (gMS[[reg]Dx Test) Differentiate Newly Diagnosed Relapsing Remitting Multiple Sclerosis Patients from Other Inflammatory Demyelinating Disease Patients within One Year from Diagnosis
MS and Related Diseases
(-)
004
Authors/Disclosures
No disclosure on file
Hollie K. Schmidt (Accelerated Cure Project) Ms. Schmidt has received personal compensation for serving as an employee of Accelerated Cure Project for MS.
No disclosure on file
No disclosure on file
Hayrettin Tumani, MD (Universitatsklinik Ulm RKU) Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Johannes Brettschneider, MD (University of Ulm, Neurology) No disclosure on file
No disclosure on file
Sven O. Jarius, MD (University of Heidelberg) Dr. Jarius has nothing to disclose.
Brigitte Wildemann, MD (University Hospital Heidelberg, Department of Neurology) The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Diego Franciotta, MD (C.M.C. Momdino) Dr. Franciotta has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Nir Dotan No disclosure on file